awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33434322-A4644E02-8B8E-4A72-98C9-1471F38F0554
Q33434322-A4644E02-8B8E-4A72-98C9-1471F38F0554
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33434322-A4644E02-8B8E-4A72-98C9-1471F38F0554
Phase II Study of Alemtuzumab (CAMPATH-1) in Patients with HTLV-1-Associated Adult T-cell Leukemia/lymphoma.
P2860
Q33434322-A4644E02-8B8E-4A72-98C9-1471F38F0554
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33434322-A4644E02-8B8E-4A72-98C9-1471F38F0554
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
009387241b3d30a1bc46daec29f3a7f328fb476b
P2860
Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphoma.